Skip to content
Dsm-Firmenich Adare Biome

dsm-firmenich invests € 275 Million into Adare Biome

Share this article

Adare Biome, a unit of Adare Pharma Solutions (CDMO), is a historic player in the development and manufacturing of postbiotic ingredients. The agreement will help the dutch-swiss group dsm-firmenich reinforce its “Health from the Gut” strategy.


Tom Sellig, CEO of Adare Pharma Solutions, commented: “As part of our efforts to take Adare Biome to the next level and realize the growth potential of postbiotic products, dsm-firmenich represents the ideal company. They have the infrastructure and strong marketing and scientific research capabilities we need to take full advantage of the major scientific research we have carried out over the years. This divestment will provide Adare Pharma Solutions with additional resources to carry out its core activities as a specialist contract manufacturing and development organization (CDMO), and will strengthen its position as a world-class outsourcing partner within the pharmaceutical industry.”


Through its B2C i-Health unit, dsm-firmenich plans to expand the availability of Lactéol®, Adare Biome’s over-the-counter postbiotic supplement for digestive disorders. The development of postbiotic ingredients in B2B will lead to opportunities in dietary supplements, early life nutrition, medical nutrition and improved nutrition for the undernourished. The acquisition of Adare Biome will also position dsm-firmenich as a market leader in microbiome modulation for companion animals, and expand its range of animal health products, whose stable postbiotics make it possible to integrate them into premium food solutions.


Philip Eykerman, dsm-firmenich’s President of Health, Nutrition and Care, said: “As a world leader in the research and manufacture of postbiotic products, and with over a century of scientific research experience in its field, Adare Biome is a perfect fit for dsm-firmenich and will complement three of our four business units. The Adare Biome teams will make a major contribution to the implementation of our “Health from the Gut” strategy, and will enable us to accelerate the creation of next-generation biotics to support human and animal health. We are delighted to (…) to offer Adare Biome products to our customers and provide faster and more effective access to the proven benefits of postbiotic products to more people around the world.”


Source: Press release